 EMERYVILLE, Calif., Sept. 29, 2021 GLOBE NEWSWIRE -- 4D Molecular Therapeutics Nasdaq: FDMT, a clinical-stage gene therapy company harnessing the power of directed evolution for targeted gene therapies, announced that management will participate in Chardans 5th Annual Genetic Medicines Conference being held virtually on Monday, October 4. Details of the fireside chat are as follows: 